ArticleScientific reports2026
Facile and efficient synthesis of silver nanoparticles using Stachys viscosa with phenolic profiling, antioxidant potential and cytotoxic activity.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Silver nanoparticles (AgNPs@Sv) were green synthesized utilizing the Stachys viscosa. High analytical techniques determined the structure and properties of AgNPs@Sv. UV-Vis analysis showed a maximum absorbance at 419 nm. FTIR determined the functional groups of AgNPs@Sv. The hydroxyl group was observed at 3260 cm− 1. The TEM analysis revealed that the nanomaterials had a spherical size of 12.1 nm. The stability of nanomaterials was disclosed by zeta potential (-38.7 mV). Quantification of natural compounds in S. viscosa was achieved by LC-MS/MS measurement (µg/g extract). Shikimic acid (39.71), chlorogenic acid (5.49), vanillic acid (2.64), and salicylic acid (1.77) were determined as main compounds. The antiproliferative effects of the extract and AgNPs@Sv were assessed using the human colorectal adenocarcinoma cell line Caco-2, the human pancreatic adenocarcinoma cell line Capan-1, and the L929 fibroblast cell line. The cell viability of Caco-2 cell lines, when exposed to AgNPs@Sv and extract, was measured as (%) 25.6 ± 0.6 and 30.6 ± 0.6, respectively, at 1.0 mg/mL. In addition, the cell viability of Capan-1 cell lines, when exposed to AgNPs@Sv and the extract, was detected as (%) 24.75 ± 0.7 and 31.92 ± 1.74 at 1.0 mg/mL, respectively. The viability of healthy L929 cell lines was determined as 75.94 ± 1.38 and 82.80 ± 1.95 at 1.0 mg/mL, respectively, when AgNPs@Sv and extract were used. AgNPs@Sv exert cytotoxic effects on cancer cells primarily by activating apoptosis-related pathways. In addition, the antioxidant potential of the extract and nanoparticles was assessed using the DPPH, ABTS, and hydroxyl radical scavenging assays. The nanoparticles displayed high antioxidant activity. AgNPs@Sv can be considered as an anticancer and antioxidant agent for drug progress.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.